Literature DB >> 17645692

Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma.

Tiziana Genovese1, Emanuela Mazzon, Concetta Crisafulli, Emanuela Esposito, Rosanna Di Paola, Carmelo Muià, Paolo Di Bella, Placido Bramanti, Salvatore Cuzzocrea.   

Abstract

This study investigates the effects of combination therapy with melatonin and dexamethasone on the degree of spinal cord injury caused by the application of vascular clip in mice. Spinal cord injury in mice resulted in severe trauma, characterized by edema, neutrophil infiltration, and apoptosis (measured by terminal deoxynucleotidyltransferase-mediated UTP end labeling staining, and immunoreaction of Bax, Bcl-2, and Fas Ligand). Infiltration of the spinal cord tissue with neutrophils (measured as increase in myeloperoxidase activity) was associated with enhanced immuno- histochemical and functional alterations revealed, respectively, by an increased of tumor necrosis factor (TNF)-alpha immunoreactivity, NOS as well as nitrotyrosine and loss of hind leg movement in spinal cord injury (SCI)-operated mice. In contrast, the degree of neutrophil infiltration at different time points, cytokine expression, histologic damage iNOS expression, apoptosis, was markedly reduced in the tissues obtained from SCI-treated mice with the combination therapy, and the motor recovery was also ameliorated. No anti-inflammatory effect was observed in animals treated with melatonin (10 mg/kg) or with dexamethasone (0.025 mg/kg) alone. This study shows that the combination therapy with melatonin and dexamethasone reduces the degree of secondary damage associated with spinal cord injury in mice, and supports the possible use of melatonin in combination with steroids to reduce the dose and the side effects related with the use of steroids for the management of inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645692     DOI: 10.1111/j.1600-079X.2007.00454.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  11 in total

1.  Melatonin as an adjuvant therapy in patients with rheumatoid arthritis.

Authors:  Ahmet Korkmaz
Journal:  Br J Clin Pharmacol       Date:  2008-05-27       Impact factor: 4.335

Review 2.  Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Authors:  Anthony E Kline; Jacob B Leary; Hannah L Radabaugh; Jeffrey P Cheng; Corina O Bondi
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

Review 3.  Antioxidant therapies in traumatic brain and spinal cord injury.

Authors:  Mona Bains; Edward D Hall
Journal:  Biochim Biophys Acta       Date:  2011-11-04

4.  Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-α, and matrix metalloproteinase-9 after spinal cord injury in mice.

Authors:  Lei Mao; Handong Wang; Liang Qiao; Xiaoliang Wang
Journal:  Mediators Inflamm       Date:  2010-08-24       Impact factor: 4.711

5.  Does the administration of melatonin during post-traumatic brain injury affect cytokine levels?

Authors:  Fatemeh Dehghan; Nader Shahrokhi; Mohammad Khaksari; Zahra Soltani; Gholamreza Asadikorom; Ali Najafi; Nava Shahrokhi
Journal:  Inflammopharmacology       Date:  2017-11-20       Impact factor: 4.473

6.  Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI.

Authors:  David M Cohen; Chirag B Patel; Pallavi Ahobila-Vajjula; Laura M Sundberg; Tessy Chacko; Shi-Jie Liu; Ponnada A Narayana
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

7.  Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats.

Authors:  Supriti Samantaray; Eric A Sribnick; Arabinda Das; Varduhi H Knaryan; D Denise Matzelle; Anil V Yallapragada; Russel J Reiter; Swapan K Ray; Naren L Banik
Journal:  J Pineal Res       Date:  2007-12-13       Impact factor: 13.007

8.  Antiinflammatory activity of melatonin in central nervous system.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

Review 9.  Role of Caspase-8 and Fas in Cell Death After Spinal Cord Injury.

Authors:  Daniel Sobrido-Cameán; Antón Barreiro-Iglesias
Journal:  Front Mol Neurosci       Date:  2018-04-03       Impact factor: 5.639

Review 10.  Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers.

Authors:  Sangiliyandi Gurunathan; Min-Hee Kang; Jin-Hoi Kim
Journal:  Cancers (Basel)       Date:  2020-06-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.